Skip to main content.

Carol M. Ulloa, M.D.

Carol Ulloa portrait
Clinical Associate Professor, Neurology

Clinical Associate Professor, Neurosurgery

Epilepsy Services Program Director, The University of Kansas Health System, Neurology

Director, Epilepsy Division, Neurology


Professional Background

Carol Ulloa, M.D., is an associate professor of neurology at the University of Kansas Medical Center and director of the Comprehensive Epilepsy Center at The University of Kansas Health System.

Dr. Ulloa attended medical school at the University of Missouri-Kansas City. After completing her neurology residency at Boston University, she subspecialized in the fields of clinical neurophysiology and epilepsy during a two-year fellowship at New York Presbyterian Hospital-Weill Cornell Medical Center. She joined the faculty at Geisinger Health System in Pennsylvania for five years, where she served as associate director of neurology. As a Missouri native, she returned to her roots in the Midwest and joined the University of Kansas Medical Center in 2015.

Dr. Ulloa is a board certified neurologist with subspecialty certification in epilepsy by the American Board of Neurology and Psychiatry. Her main clinical interests are seizures, epilepsy, intractable epilepsy, video EEG monitoring and surgical interventions for the treatment of epilepsy. Dr. Ulloa leads a multidisciplinary team of epileptologists, neurosurgeons, radiologists, and neuropsychologists that provides state-of-the-art comprehensive care to epilepsy patients at The University of Kansas Health System.

She is a Fellow of the American Epilepsy Society.

Education and Training
  • MD, Univ of Missouri-Kansas City
  • Other, New York Presbyterian Hospital, Columbia University Medical Center
  • Other, Boston University School of Medicine
  • Other, Boston University School of Medicine
  • Other, New York Presbyterian Hospital, Weill Cornell Medical Center
Licensure, Accreditations & Certifications
  • Epilepsy, American Board of Psychiatry and Neurology
  • Kansas Board of Healing Arts
  • Neurology, American Board of Psychiatry and Neurology
  • New York Board of Healing Arts
Professional Affiliations
  • Missouri Kansas Neurological Society, Member, 2018 - Present
  • Kansas City Epilepsy Society, Member, 2017 - Present
  • Kansas City Neurology/Neurosurgery Society (now Kansas City Clinical Neuroscience Society), Member, 2015 - Present
  • American Epilepsy Society, Member, 2010 - Present
  • American Academy of Neurology, Member, 2008 - Present

Publications
  • Ulloa CM, Towfigh AA, Safdieh JE. 2009. Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. Neuropsychiatric Disease and Treatment, 5, 467-476
  • Ulloa CM, Gilliam FG. 2011. Improving care for patients with epilepsy. Nat Rev Neurol, 7 (4), 195-196
  • Sethi NK, Ulloa CM, Solomon GE, Lopez L. 2012. Diagnostic utility of routine EEG study in identifying seizure as the etiology of the index event in patients referred with a diagnosis of migraine and not otherwise specified headache disorders. EEG Neurosci, 43 (4), 323-325
  • Sethi NK, Ulloa CM, Solomon GE. 2012. EEG in syncope: useful for not?. J Clin Neurophysiol, 29 (4), 353
  • Ulloa C, Ortiz-Guerrero G, Pearson C, Leever J, Landazuri P, Uysal U. 2020. Ictal multicomponent agraphia in left temporal lobe epilepsy: a rarely captured seizure semiology. Neurology, 94 (1), 42-43